A new year, a new episode!

In this episode, Sapient’s Tanya Nguen joins us to bring a unique perspective that transcends traditional boundaries, offering valuable insights into treating clinical human diseases. Tanya Nguyen shares insights from her college research in neuroscience, exploring the formative years that shaped her journey. Discover the profound influence of clinical experiences on Tanya's approach to research and how Sapient has provided the opportunity to contribute to science at various stages of drug development.

0:51: The transition from a "non-Omics" background to shaping the future of clinical disease treatment

2:19: Impact of her college research in neuroscience during her formative years

6:13: Connecting research and clinical outcomes: Sapient's role in all stages of drug development 

7:29: Tanya shares her "OMG moment" that set her on the path of scientific exploration

9:02: Significant of mass spectrometry on in the broad Omics field, spanning from early-stage discovery to patient-oriented applications

10:51 - The pivotal role Omics plays at Sapient and the exciting metrics and stats the organization utilizes

13:06 - The future of Omics at Sapient, focusing on ramping up metabolomics, lipidomics, and proteomics to make a lasting impact beyond the genome

18:05 - A glimpse into a day at Sapient and the unique Sapient approach

19:39 🍹 Bonus Content: Discover Tanya’s hobby outside the lab

Hosted on Acast. See acast.com/privacy for more information.